← Open Payments lookup

LYNNETTE HOLLON: Open Payments

NPI 1629097324 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,307 in 121 payments from 26 companies in 2025. Trend: 2023 $2,335 · 2024 $2,339 · 2025 $2,307

Food & beverage: $2,307
CompanyPaymentsAmount
Lilly USA, LLC14$257
PFIZER INC.11$249
AstraZeneca Pharmaceuticals LP14$241
Boehringer Ingelheim Pharmaceuticals, Inc.11$227
GlaxoSmithKline, LLC.10$183
Novo Nordisk Inc9$161
Bayer Healthcare Pharmaceuticals Inc.10$137
Otsuka America Pharmaceutical, Inc.5$121
SANOFI-AVENTIS U.S. LLC3$73
Gilead Sciences, Inc.3$72

Products named: JARDIANCE, MOUNJARO, Kerendia, TRELEGY ELLIPTA, REXULTI, AIRSUPRA, ELIQUIS, FARXIGA.

Industry payments across TX — which companies pay providers there.